Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

European Commission approves Forxiga for type 1 diabetes

March 25, 2019

Evox secures funding to support development of exosome therapy to treat argininosuccinic aciduria

March 22, 2019

Innovent initiates Chinese phase IIa study of IBI-306 for hypercholesterolemia

March 21, 2019

HSJ-633 prevents inflammation-induced preterm birth and fetal tissue injury in vivo

March 21, 2019

OBE-022 demonstrates promising safety and PK in the first part of the PROLONG study

March 20, 2019

Millendo Therapeutics initiates pivotal phase IIb/III ZEPHYR study of livoletide

March 20, 2019

Crinetics initiates phase II program for CRN-00808 in acromegaly

March 19, 2019

How the other half controls appetite

March 19, 2019

First-in-human data presented for KL-1333

March 18, 2019

FP-101 relieves hot flashes in menopausal women and women taking tamoxifen

March 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...